CEO level clarity with R&D level insight
For over 20 years, Candesic has led industry thinking and brought unrivalled expertise to client issues. Our corporate mission is to improve care outcomes, and drive better and longer lives, by combining strategy with deep sector expertise. Our team of 40 professionals combines deep medical, science, business and technology expertise. While we serve clients across multiple sectors and geographies, our objective remains a constant; to provide CEO level clarity with R&D level insight. In our daily work we stand for our core values of excellence, initiative, collaboration, passion and inclusivity.
Candesic Insights
Counting the cost of fixing the waiting list crisis
Insights
25 Jul 24
In the latest edition LaingBuisson HealthcareMarkets, Candesic Senior Partner Dr Michelle Tempest and Senior Engagement Manager Jack Zeng count the cost of fixing English NHS waiting list - ...
CytoReason receives $80m investment
Deal Announcements
23 Jul 24
Candesic provided commercial due diligence to the investors providing $80m of growth capital to pioneering AI drug discovery company CytoReason. CytoReason, which offers life sciences companies ...
Duke Street invests in AGITO Medical
Deal Announcements
16 Jul 24
Leading mid-market private equity group Duke Street is acquiring mobile rental solutions and pre-owned imaging equipment and spare parts supplier AGITO Medical from Philips. The Candesic team led ...